<DOC>
	<DOC>NCT01533129</DOC>
	<brief_summary>The study searched for answers to two questions 1. What is the effect of testosterone replacement therapy on endothelial dysfunction, inflammation and insulin resistance? 2. Regarding the above parameters, is there any difference between daily transdermal testosterone implementation and intramuscular injection performed in three weeks.</brief_summary>
	<brief_title>The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Men Treatment naive Hypogonadotrophic hypogonadism Previous history of androgen replacement Chronic metabolic disorders</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Hypogonadism</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Testosterone replacement therapy</keyword>
</DOC>